Post-Cataract Surgery Eye Drop Regimen

Core Medication Regimen

The standard post-cataract surgery regimen consists of a topical antibiotic (moxifloxacin 0.5% three times daily for 7 days) combined with a topical corticosteroid (prednisolone acetate 1% or loteprednol four times daily, tapered over 3-5 weeks), with preservative-free formulations strongly preferred to minimize ocular surface toxicity 1
Preservative-free formulations should be prioritized when available to reduce ocular surface irritation 1
Typical taper for prednisolone acetate 1% is 4 times daily for 1 week, then 2-4 times daily for 1-2 weeks, then 2 times daily for 2-3 weeks 1

High-risk patients, including those with history of dry eye disease, current use of multiple topical medications, history of cataract surgery-induced dry eye, contact lens use, or diabetes, should strongly prioritize preservative-free eye drops 1

Critical monitoring points include Day 1, Weeks 1-2, 1 month, 2 months, and 3-6 months, to check for infection, inflammation, dry eye occurrence, ocular surface damage, visual acuity, and intraocular pressure 1

Using preserved drops in high-risk patients significantly increases risk of ocular surface toxicity and dry eye exacerbation 1
Inadequate aggressive management of dry eye disease, which can be caused or exacerbated by cataract surgery, requires more frequent and aggressive therapy than preoperative management 1

The American Academy of Ophthalmology recommends preservative-free NSAIDs like ketorolac for use within the first post-surgical month to manage dry eye disease and inflammation 2
Preservative-free formulations, such as ketorolac 0.45%, are preferred to minimize ocular surface irritation, especially in high-risk patients 2
The use of preservative-free ketorolac may be more expensive than preserved versions, but it is a recommended component of post-surgical care to reduce inflammation and pain 2
Consider the full medication regimen to avoid drug interactions or cumulative toxicity from multiple eye drops 2

The American Academy of Ophthalmology recommends topical corticosteroids as the standard of care for routine postoperative inflammation control, with a Medrol (methylprednisolone) dose pack being generally safe for use in patients after cataract surgery 3
Close IOP monitoring is essential with any corticosteroid regimen, as prolonged use can cause significant IOP elevation in a substantial proportion of patients, according to the American Academy of Ophthalmology 4

The American Academy of Ophthalmology suggests avoiding systemic steroids in patients with uncontrolled glaucoma or a history of steroid response, and instead using topical therapy when feasible and the patient is compliant 4
Systemic steroids, such as a Medrol pack, may be considered for patients with documented compliance issues, a history of uveitis, or high inflammatory risk, as recommended by the American Academy of Ophthalmology 3